Pharma Mar (PHMMF) News Today $75.00 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period New miRNA inhibitor could extinguish the 'inflammatory fire' that stroke causes in the brainOctober 29, 2024 | msn.comPHMMF Pharma Mar, S.A.October 10, 2024 | seekingalpha.comPharma Mar (OTCMKTS:PHMMF) Trading 31.1% Higher Pharma Mar (OTCMKTS:PHMMF) Stock Price Up 31.1%August 29, 2024 | marketbeat.comChemists develop modular approach for creating important class of pharmaceutical compoundsJuly 19, 2024 | msn.comRevolutionizing Pharmaceutical Manufacturing: The Visionary Work of Tejesh MarsaleMay 18, 2024 | markets.businessinsider.comTransforming Pharmaceutical Manufacturing: The Visionary Work of Tejesh MarsaleMay 16, 2024 | msn.comPharming Group’s Strong Performance and Growth Prospects Justify Buy RatingMarch 18, 2024 | markets.businessinsider.comMar-a-lagoMarch 16, 2024 | newsweek.comPersica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back painMarch 7, 2024 | markets.businessinsider.comPharma Mar SAU (PHMR)February 17, 2024 | investing.comPfizer’s 2024 Comeback: A Dividend Gem in the Pharma MarketFebruary 1, 2024 | investorplace.comTwo new databases combine computer science and pharmaceutical researchJanuary 9, 2024 | msn.comFirst West Africa Healthcare, Lab, & Pharma Week 2024 To Hold In NigeriaNovember 29, 2023 | msn.comPharma Mar SA PHMNovember 6, 2023 | morningstar.comPiramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024October 28, 2023 | markets.businessinsider.comPharma Mar S.A.July 15, 2023 | barrons.comYifan PharmaceuticalJune 21, 2023 | forbes.comPHM.MC - Pharma Mar, S.A.June 6, 2023 | finance.yahoo.comNEEDHAM & COMPANY INC. Maintains Pharma Mar (XMAD:PHM) Buy RecommendationApril 22, 2023 | msn.comPharmaceutical Excipients Market Top Players By 2031March 27, 2023 | marketwatch.comPharmaceutical company to open in McHenryMarch 25, 2023 | news.yahoo.comInnate Pharma (IPHA) Receives a Buy from H.C. WainwrightMarch 24, 2023 | markets.businessinsider.comBig Pharma companies back new startup out of Mass General BrighamMarch 16, 2023 | bizjournals.comPiramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023November 9, 2022 | markets.businessinsider.comEuropean Commission suspects pharma group Teva broke antitrust rulesOctober 10, 2022 | yahoo.comPharmacists Database List of Emails, Phone Numbers, Contact InformationAugust 30, 2022 | apnews.comLife Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variantsJanuary 11, 2022 | finance.yahoo.comPharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in TaiwanNovember 11, 2021 | finanznachrichten.deSpain's PharmaMar posts 58% drop in 9-mth profit despite higher revenuesOctober 28, 2021 | news.yahoo.comSpain's PharmaMar nine-month net profit falls 58%October 28, 2021 | reuters.comSpain's PharmaMar sales rise on demand for cancer treatmentsJuly 29, 2021 | nasdaq.com Get Pharma Mar News Delivered to You Automatically Sign up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. PHMMF Media Mentions By Week PHMMF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHMMF News Sentiment▼0.100.43▲Average Medical News Sentiment PHMMF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHMMF Articles This Week▼10▲PHMMF Articles Average Week Get Pharma Mar News Delivered to You Automatically Sign up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BRTHY News JAPSY News BMRRY News UDIRF News HTCMY News ROHCY News APNHY News SOMMY News KCDMY News GLAPY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PHMMF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma Mar, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharma Mar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.